Advertisement
RayBiotech
RayBiotech

MRCP and pancreatic cancer

NEW YORK, July 17 (Praxis Press) Magnetic resonance cholangiopancreatography (MRCP) is a promising alternative to endoscopic retrograde cholangiopancreatography (ERCP), but its accuracy has not been proven in a large controlled study. Adamek and colleagues prospectively compared MRCP and ERCP for the differentiation of pancreatic lesions in 124 patients with suspected pancreatic cancer (see paper). For the diagnosis of pancreatic cancer, MRCP had a sensitivity of 84% and a specificity of 97%, wh

July 21, 2000

NEW YORK, July 17 (Praxis Press) Magnetic resonance cholangiopancreatography (MRCP) is a promising alternative to endoscopic retrograde cholangiopancreatography (ERCP), but its accuracy has not been proven in a large controlled study. Adamek and colleagues prospectively compared MRCP and ERCP for the differentiation of pancreatic lesions in 124 patients with suspected pancreatic cancer (see paper). For the diagnosis of pancreatic cancer, MRCP had a sensitivity of 84% and a specificity of 97%, whereas ERCP had a sensitivity of 70% and a specificity of 94%. MRCP is at least as sensitive as ERCP for the detection of pancreatic cancer and may prevent unnecessary exploratory procedures.

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
Panasonic
Panasonic

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
New England BioLabs
New England BioLabs
Advertisement
NeuroScientistNews
NeuroScientistNews